Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104


A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.

Najdi R, Syed A, Arce L, Theisen H, Ting JH, Atcha F, Nguyen AV, Martinez M, Holcombe RF, Edwards RA, Marsh JL, Waterman ML.

Oncogene. 2009 Nov 26;28(47):4133-46. doi: 10.1038/onc.2009.271. Epub 2009 Sep 14.


Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.

Lin YY, Hsu YH, Huang HY, Shann YJ, Huang CY, Wei SC, Chen CL, Jou TS.

J Clin Invest. 2012 May;122(5):1881-94. doi: 10.1172/JCI45661. Epub 2012 Apr 2.


Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.

Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min do S.

Cancer Res. 2010 May 15;70(10):4233-42. doi: 10.1158/0008-5472.CAN-09-3470. Epub 2010 May 4.


The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.

Chen HJ, Hsu LS, Shia YT, Lin MW, Lin CM.

Biochem Pharmacol. 2012 Nov 1;84(9):1143-53. doi: 10.1016/j.bcp.2012.08.011. Epub 2012 Aug 19.


NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer.

Guo Q, Shen S, Liao M, Lian P, Wang X.

Acta Biochim Biophys Sin (Shanghai). 2010 Jul;42(7):450-6. doi: 10.1093/abbs/gmq049. Epub 2010 Jun 13.


TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.

Heijink DM, Jalving M, Oosterhuis D, Sloots IA, Koster R, Hollema H, Kleibeuker JH, Koornstra JJ, de Vries EG, de Jong S.

J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29.


DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.

Wang S, Dong Y, Zhang Y, Wang X, Xu L, Yang S, Li X, Dong H, Xu L, Su L, Ng SS, Chang Z, Sung JJ, Zhang X, Yu J.

Oncogene. 2015 May 14;34(20):2575-85. doi: 10.1038/onc.2014.201. Epub 2014 Jul 14.


Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.

Hikasa H, Sokol SY.

J Biol Chem. 2011 Apr 8;286(14):12093-100. doi: 10.1074/jbc.M110.185280. Epub 2011 Feb 1.


Inhibition of Tcf-4 induces apoptosis and enhances chemosensitivity of colon cancer cells.

Xie J, Xiang DB, Wang H, Zhao C, Chen J, Xiong F, Li TY, Wang XL.

PLoS One. 2012;7(9):e45617. doi: 10.1371/journal.pone.0045617. Epub 2012 Sep 24.


Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.

Feng Y, Bommer GT, Zhai Y, Akyol A, Hinoi T, Winer I, Lin HV, Cadigan KM, Cho KR, Fearon ER.

Cancer Res. 2007 Jan 15;67(2):482-91.


Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.

Dehner M, Hadjihannas M, Weiske J, Huber O, Behrens J.

J Biol Chem. 2008 Jul 11;283(28):19201-10. doi: 10.1074/jbc.M710366200. Epub 2008 May 16.


Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.

Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weinberger P, Psyrri A.

Mol Cancer Res. 2010 Mar;8(3):433-43. doi: 10.1158/1541-7786.MCR-09-0345. Epub 2010 Mar 9.


Lymphoid enhancer factor/T cell factor expression in colorectal cancer.

Waterman ML.

Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):41-52. Review.


ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.

Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.

Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15.


Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.

Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, Wells JM.

Mol Cell Biol. 2007 Nov;27(22):7802-15. Epub 2007 Sep 17.


Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.

Souazé F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, Bruyneel E, Comperat E, Faux MC, Mareel M, Rostène W, Fléjou JF, Gespach C, Forgez P.

Carcinogenesis. 2006 Apr;27(4):708-16. Epub 2005 Nov 19.


Calcium, calcium-sensing receptor and colon cancer.

Whitfield JF.

Cancer Lett. 2009 Mar 8;275(1):9-16. doi: 10.1016/j.canlet.2008.07.001. Epub 2008 Aug 23. Review.


Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.

Zhang Y, Toh L, Lau P, Wang X.

J Biol Chem. 2012 Sep 21;287(39):32494-511. Epub 2012 Jul 31.


The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.

González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A.

Oncogene. 2005 Feb 3;24(6):1098-103.


Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.

Larriba MJ, Ordóñez-Morán P, Chicote I, Martín-Fernández G, Puig I, Muñoz A, Pálmer HG.

PLoS One. 2011;6(8):e23524. doi: 10.1371/journal.pone.0023524. Epub 2011 Aug 15.

Supplemental Content

Support Center